Consolidated Statements of Earnings - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Income Statement [Abstract]
Net Sales	$ 7,024.5	$ 7,982.2	$ 7,932.9
Type of Revenue [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Cost of products sold, excluding intangible asset amortization	$ 2,128.3	$ 2,252.6	$ 2,271.9
Type of Cost, Good or Service [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Intangible asset amortization	$ 597.6	$ 584.3	$ 595.9
Research and development	372.0	449.3	391.7
Selling, general and administrative	3,177.8	3,343.8	3,379.3
Goodwill and intangible asset impairment	645.0	70.1	979.7
Restructuring and other cost reduction initiatives	116.9	50.0	34.2
Quality remediation	50.9	82.4	146.9
Acquisition, integration and related	23.8	12.2	99.5
Operating expenses	7,112.3	6,844.7	7,899.1
Operating (Loss) Profit	(87.8)	1,137.5	33.8
Other income (expense), net	25.4	(4.8)	(15.6)
Interest expense, net	(212.0)	(226.9)	(289.3)
(Loss) Earnings before income taxes	(274.4)	905.8	(271.1)
(Benefit) provision for income taxes	(137.0)	(225.7)	108.2
Net (Loss) Earnings	(137.4)	1,131.5	(379.3)
Less: Net earnings (loss) attributable to noncontrolling interest	1.5	(0.1)	(0.1)
Net (Loss) Earnings of Zimmer Biomet Holdings, Inc.	$ (138.9)	$ 1,131.6	$ (379.2)
(Loss) Earnings Per Common Share - Basic	$ (0.67)	$ 5.52	$ (1.86)
(Loss) Earnings Per Common Share - Diluted	$ (0.67)	$ 5.47	$ (1.86)
Weighted Average Common Shares Outstanding
Basic	207.0	205.1	203.5
Diluted	207.0	206.7	203.5